Primary and secondary feasibility objectives were matched with the following occurrences : 70.2 % of eligible patients finally recruited ; 4.2 % of randomization refusals ; 26.6 patients/month recruited ; 100 % patients receiving a blinded treatment ; 97.5 % compliance and 100 % completion .